C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline AMT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction TUYA Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Limited Disclosure EXLS Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Pending FEIM Q1 2026 Earnings EPS Falls Short of Expectations Yet Stock Surges Over 13 PSQ Holdings Inc PSQH Q1 2026 Earnings Narrower Loss Beats Estimates Yet Stock Declines